Scarica l'app Stockscreener
3.25
7.97%
0.24
Pre-mercato:
3.12
-0.13
-4.00%
Sab Biotherapeutics Inc Azioni (SABS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | 0.1147 | - | 0.2631 |
Operating Expenses
|
9.65%
9.7321
|
10.77 | 10.12 | 11.31 | 10.46 |
| Operating Income/Loss |
9.65%
-9.7321
|
-10.77 | -10.01 | -11.31 | -10.20 |
| Nonoperating Income/Loss |
106.86%
-0.3822
|
5.5753 | -1.3859 | 0.96 | 2.8662 |
| Income/Loss From Continuing Operations Before Tax |
94.63%
-10.11
|
-5.1968 | 24.03 | -10.35 | -7.3355 |
| Income/Loss From Continuing Operations After Tax |
94.63%
-10.11
|
-5.1968 | -11.39 | -10.35 | -7.3355 |
|
Net Income/Loss
|
94.63%
-10.11
|
-5.1968 | -11.39 | -10.35 | -7.3355 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.03%
9.2945
|
9.2916 | 0.00982 | 9.2592 | 9.255 |
| Diluted Average Shares |
0.03%
9.2945
|
9.2916 | 0.00982 | 9.2592 | 9.255 |
| Basic Earnings Per Share |
94.64%
-1.09
|
-0.56 | -1.23 | -1.12 | -0.79 |
| Diluted Earnings Per Share |
94.64%
-1.09
|
-0.56 | -1.23 | -1.12 | -0.79 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):